tradingkey.logo

Immunoprecise Antibodies Ltd

IPA
Ver gráfico detallado
2.070USD
0.0000.00%
Cierre 02/06, 16:00ETCotizaciones retrasadas 15 min
95.54MCap. mercado
PérdidaP/E TTM

Immunoprecise Antibodies Ltd

2.070
0.0000.00%
Intraday
1m
30m
1h
D
W
M
D

Hoy

0.00%

5 Días

0.00%

1 Mes

0.00%

6 Meses

+9.52%

Año hasta la fecha

0.00%

Un año

+307.48%

Ver gráfico detallado

Puntuación de acciones TradingKey

No hay puntuación de la acción disponible debido a la falta de datos.

Immunoprecise Antibodies Ltd Noticias

Próximamente más noticias, permanezca atento...

Indicadores financieros

BPA

La empresa aún no ha revelado los datos relevantes.

Ingresos totales

La empresa aún no ha revelado los datos relevantes.

Información de Immunoprecise Antibodies Ltd

ImmunoPrecise Antibodies Ltd. is a biotechnology company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies. It has several subsidiaries in North America and Europe including entities, such as Talem Therapeutics LLC, BioStrand BV, ImmunoPrecise Antibodies (Canada) Ltd. and ImmunoPrecise Antibodies (Europe) B.V. (collectively, the IPA Family). Its Contract Research Organizations (CRO) services include B cell Select; Phage Display; DeepDisplay; Abthena Bispecifics; LucinaTech Humanization; Affinity Maturation; Immunization, hybridoma, sequencing; rPEx protein manufacturing, and Cell line development. The Company utilizes custom antigen modeling, target analysis using Natural Language Processing and the HYFTTM analysis to lay the groundwork for the subsequent experimental phases.
Símbolo de cotizaciónIPA
CompañíaImmunoprecise Antibodies Ltd
Director ejecutivoDr. Jennifer Lynne Bath, Ph.D.
Sitio Webhttps://www.ipatherapeutics.com/
KeyAI